Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Colorectal Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Breast Neoplasms 17Lung Neoplasms 15Colonic Neoplasms 11Head and Neck Neoplasms 9Rectal Neoplasms 7Glioblastoma 5Prostatic Neoplasms 4Precancerous Conditions 4Mouth Neoplasms 4Esophageal Neoplasms 4Central Nervous System Neoplasms 4Adenomatous Polyposis Coli 4Uterine Cervical Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Sarcoma 3Neuroblastoma 3Neoplasms 3Liver Neoplasms 3Gliosarcoma 3Glioma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Smoking 2Salivary Gland Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma × Celecoxib × Clear all
NCT00357500 2014-10-01

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
101 enrolled 10 charts
CNSLymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡